✓
Open
4 Aug 2021
✓
Close
6 Aug 2021
3
Allotment
—
✓
Listing
Mon, Aug 16, 2021
Price Band
₹448 to ₹460
Issue Size
87,29,023 shares (agg. up to ₹402 Cr)
Lot Size
30 Shares
Listing Date
Mon, Aug 16, 2021
✦ AI Insight
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 14.54x |
Restated Financials (₹ Cr.)
| Period Ended | 31 Mar 2021 | 31 Mar 2020 | 31 Mar 2019 |
|---|---|---|---|
| Assets | 296.12 | 338.49 | 298.18 |
| Total Income | 430.70 | 331.34 | 311.53 |
| Profit After Tax | 15.57 | 16.21 | 63.82 |
| EBITDA | 54.52 | 34.00 | 37.74 |
| NET Worth | 199.12 | 209.66 | 193.59 |
| Reserves and Surplus | 192.71 | 203.25 | 187.17 |
| Total Borrowing | 31.32 | 27.43 | 29.91 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Glenmark Life Sciences Ltd. | Mainboard | ₹1,513.60 Cr | ₹720 | null | ₹748.50 | +3.96% | ₹1,372.00 |
| Gland Pharma Ltd. | Mainboard | ₹6,479.55 Cr | ₹1500 | null | ₹1,819.55 | +21.30% | ₹2,959.30 |
| Walpar Nutritions Ltd. | SME | ₹6.60 Cr | ₹55 | null | ₹57.00 | +3.64% | ₹23.00 |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Purchase of equipment required for (i) capacity expansion of the existing facility at the Dehradun Plant – IV; and (ii) addition of injectables dosage capability at our existing facility at Dehradun Plant – II | 50.00 |
| 2 | Funding incremental working capital requirements of the Company | 47.56 |
| 3 | Repayment/prepayment of certain of the borrowings | 20.00 |
| 4 | General corporate purposes( | 34.60 |
About Windlas Biotech IPO
Updated on Aug 5, 2026
Contact Details
Windlas Biotech Ltd. Address40/1, Mohabewala Industrial AreaDehradun, Uttarakhand, 248110+91 135 6608000grievance@windlasbiotech.comVisit Website